Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 17Peritoneal Neoplasms 13Fallopian Tube Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 5Carcinoma, Ovarian Epithelial 5Hyperthermia 3Gastrointestinal Neoplasms 3Appendiceal Neoplasms 3Adrenocortical Carcinoma 3Sarcoma 2Rhabdomyosarcoma 2Neoplasms 2Mesothelioma, Malignant 2Mesothelioma 2Glioma 2Glioblastoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Carcinoma 2Brain Neoplasms 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Recurrence 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pleural Effusion, Malignant 1Peritoneal Cavity Cancer 1Pelvic Neoplasms 1

Interventions

apatinib 3Taxes 3S 1 (combination) 3Oxaliplatin 3Cisplatin 3sintilimab 2Paclitaxel 2Hyperthermic Intraperitoneal Chemotherapy 2Gastrectomy 2Docetaxel 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tipiracil 1taxane 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1andecaliximab 1XELOX 1Trifluridine 1Tegafur 1Tadalafil 1SHR-1701 1Resistance Training 1Platinum 1Nivolumab 1Magnetic Resonance Spectroscopy 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastric Adenocarcinoma × Cytoreduction Surgical Procedures × Clear all
NCT07178808 2026-05-01

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Banner Health

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡